Clinical trial
Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of…
NCT00446511 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00446511 |
|---|---|
| Title | Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension |
| Official title | An Extension to Study Protocol CVAL489K2302 to Evaluate the Long Term Safety, Tolerability and Efficacy of Valsartan in Children 6 to 17 Years of Age With Hypertension, Versus Enalapril Treatment for 14 Weeks, or Combined With Enalapril Versus Enalapril for 66 Weeks in Chronic Kidney Disease… |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Valsartan, Enalapril, placebo matched to enalapril, placebo matched to valsartan |
| Enrollment | 250 |
| Start date | Jun 1, 2007 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Mar 13, 2007 |
| Last update posted | Jul 12, 2011 |
| Countries | Belgium, France, Germany, Hungary, India, Italy, Poland, Turkey (Türkiye), United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: